XML 65 R49.htm IDEA: XBRL DOCUMENT v3.26.1
Note 5 - Discontinued Operations (Details Textual) - USD ($)
3 Months Ended 12 Months Ended
Feb. 18, 2025
Apr. 12, 2024
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Mar. 31, 2025
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Stock issued during period, shares 3,379,377          
Common stock, par value       $ 0.001 $ 0.001  
Estimated fair value       $ 151,000 $ 196,000  
Discontinued operations, Provision (benefit) for income taxes       0 0  
Estimated reduction of reserve from hazardous waste disposal vendor     $ 300,000 $ 300,000    
Share-based compensation expense on discontinued operations         $ 200,000  
GT Medical Technologies, Inc. [Member]            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Stock issued during period, shares   279,516        
Common stock, par value   $ 0.0001        
Percentage of issued and outstanding capital stock   0.50%        
Royalty agreement percentage of net sales receivable   0.50%        
GT Medical Technologies, Inc. [Member] | Royalty [Member]            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Royalties payable     $ 200,000      
GT Medical Technologies, Inc. [Member] | Net Sales of $10.0 Million or Less [Member]            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Royalty agreement percentage of net sales receivable   3.00%        
GT Medical Technologies, Inc. [Member] | Net Sales Between $10.0 and 15.0 Million [Member]            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Royalty agreement percentage of net sales receivable   4.00%        
GT Medical Technologies, Inc. [Member] | Net Sales Greater Than $15.0 Million [Member]            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Royalty agreement percentage of net sales receivable   5.00%        
GT Medical Technologies, Inc. [Member] | GT Medical Stock [Member]            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Estimated fair value   $ 200,000       $ 200,000